China Health Product Industry Report, 2004
  • Nov/2004
  • Hard Copy
  • USD $1,650
  • Pages:280
  • Single User License
    (PDF Unprintable)       
  • USD $1,800
  • Code:
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,700
  • Hard Copy + Single User License
  • USD $1,850

In 2003, the spread of SARS brought opportunities for China's health product industry, which was in recession for years. Anything that can improve health conditions represented hot selling, even out of stock. Sales revenue of health product industry increased to ¥30 billion yuan in 2003 from ¥20 billion yuan in 2002, up by 50 percent; More important, consumers’ consciousness of health care has been wakened. Along with “Health Food Association of China (HFAC)” was canceled and “China Health Technology Association” changed to “China Health Care Association”, consumers more trust in health products.

Amway achieved prominent sales performance in China in 2003, with annual sales revenue of ¥4.2 billion yuan. Meanwhile, due to the forthcoming of China's direct-selling law, Nuskin indicated  itself would enter into Chinese health product market, challenge Amway directly.

Based on the statistics from National Statistic Bureau, China Health Product Association, China Economic Information Center, China Commercial Information Center, China Medical Healthcare Association, China Economic Monitoring Center, Ministry of Health and other 500 newspapers and magazines, the report presents an in-depth analysis on China's health product sector and its segmented markets, consumption status and competition pattern; it also presents a forecast on China's health product development trends.

Part 1 Analysis on the development of China's health product sector 

1.Definition and classification of health products

2.Development of China's health product sector 
2.1 Three upgrading periods  
2.2 Six development stages 
2.3 Market status
2.4 Analysis on major economic indicators 
2.5 Retrospect of year 2003 
2.6 Prospects of health product sector

Part 2 Development status of global health product industry

3.Development summary of global health product industry

4.Development of the health product industry in major countries/regions

5.Development trends of global health product industry

6.R&D analysis 

Part 3 Market segmentation analysis of China's health product industry 

7.Calcium products 
7.1 Markey summary
7.2 Consumer analysis
7.3 Competitive pattern 
7.4 Wyeth-Whitehall Pharmaceutical Co., Ltd.
7.5 Shenzhen Neptunus Bioengineering Co., Ltd
7.6 Harbin Pharm. Group sixth 
7.7 Beijing Jinde
7.8 Harbin Pharm. Group Sanjing Pharmaceutical Co., Ltd.
7.9 Gaitianli 
7.10 Jiansu Longniqi Group Co., Ltd

8.Vitamin products 
8.1 Market development
8.2 Consumer analysis
8.3 Hangzhou Minsheng Pharmaceutical Group Co., Ltd.
8.4 Shanghai Goldpartner Biotech Co,. Ltd
8.5 Shanghai Squibb
8.6 Latest developments
8.7 Forecasts 

9.weight-losing products
9.1 Summary
9.2 Market status in the last 2 years
9.3 Consumer analysis 
9.4 Problems
9.5 Competition analysis 
9.6 Qumei Co., Ltd
9.7 Nanjing Changao Co., Ltd
9.8 Shantou Dayinxiang Co., Ltd
9.9 Prospects

10.Anti-aging products 
10.1 Consumer analysis
10.2 Competition analysis 
10.3 Jiankangyuan Group Co., Ltd
10.4 Yunnan Yunhai Group Co., Ltd
10.5 Guangzhou Yipintang Biotech Co., Ltd
10.6 Prospects

11.Products for enrichment of brain products
11.1 Summary
11.2 Market characteristics
11.3 HK Kangful International Co., Ltd
11.4 Naolingtong
12.Products for enrichment of Blood
12.1 Summary of the market development
12.2 Competition analysis 
12.3 Dong' E Ejiao Group Co., Ltd
12.4 Investment suggestions

13.Products for enrichment of Digestion & Stomach 
13.1 Market development
13.2 Consumer analysis
13.3 Shanghai Jiao Da Onlly Co., Ltd.

14.Immunity products
14.1 Market status
14.2 Ginseng market
14.3 Shenzhen Wanji Pharmaceutical Co., Ltd.

Part 4. Sizeable enterprises 

15.Chinese sizeable leading enterprises
15.1 Qindao Jiante BiotechCo., Ltd
15.2 Chengqing Taiji Group

16.Global sizeable leading enterprises
16.1 Amway America
16.2 Amway China
16.3 Roche Group
16.4 Roche China

Part 5. Marketing strategy of major brands

17.Review on the marketing strategies of major brands
17.1 Taiyangshen
17.2 Sanzhu
17.3 Naobaijin
17.4 Hongtao K

18.Marketing strategies of health product industry in China
18.1 Concept strategy
18.2 Ads Strategy
18.3 Brand strategy

19.Successful cases
19.1 Naobaijin
19.2 Alashancongrong

Part 6. Trends and investment suggestions

20.Development trends of China's health product industry
20.1 Nutrition status of Chinese people
20.2 Development of internal factors 
20.3 Development of external factors 
20.4 Prospects
20.5 Forecasts on the demand

21.Investment analysis of China's health product industry
21.1 SWOT analysis
21.2 Recommendations on the investment orientation
21.3 Market strategy
21.4 Successful service marketing modes
21.5 Marketing development trends
21.6 Position and problems of conference marketing
Development in different stages 
Variety in sales revenue
Investment structure of China's health product industry, 2003
Calcium consumption of different age groups, by month 
Sales Revenue of principle businesses for HAIWANG GROUP CO., LTD, 2001-2004
Shareholders of HAYAO and its principle products
Sales volume of 21JINWEITA 
Monthly rank of weight -losing products by sales revenue
Monthly rank of anti-aging products by sales revenue

China Pharmaceutical Distribution Industry Report, 2019-2025

China’s pharmaceutical distribution industry has sustained steady growth over the years. In 2018, the market was worth RMB2,194.5 billion, a 9.6% rise from RMB2,001.6 billion (up by 8.4% YoY) in 2017,...

China Pharmaceutical Packaging Industry Report, 2019-2025

Being incentivized by the burgeoning pharmaceuticals industry, Chinese pharmaceutical packaging market size sustained growth rates of around 10% in recent years, and outstripped RMB100 billion in 2018...

China Blood Product Industry Report, 2018-2022

The blood product industry in China develops under stimulation of industry policies and downstream demand. The country recorded total lot release volume of 64.11 million bottles of blood products in 2...

China Pharmaceutical Distribution Industry Report, 2017-2021

The Chinese pharmaceutical distribution market has developed steadily but at a slower rate in recent years. The industry rose by 10.4% year on year to RMB1.8393 trillion in 2016 and is expected to hit...

China Blood Product Industry Report, 2017-2021

China’s blood product market size mushroomed in 2016 under the impetus of liberalization of limited-price policy, price rises in varying degrees and lot release volume growth for blood products in 201...

China Pharmaceutical Packaging Industry Report, 2016-2021

Under the impetus of the fast-growing downstream pharmaceutical industry, Chinese pharmaceutical packaging market size increased year by year at the CAGR of 11.2% during 2010-2016. From 2017 to 2021, ...

China Pharmaceutical Glass Packaging Industry Report, 2014-2017

In recent years, advances in new healthcare reform have boosted market demand from China pharmaceuticals industryand driven growth in the demand from pharmaceutical packaging industry. In 2014, the Ch...

China Vitamin Industry Report,2014-2017

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total out...

China Chemical Pharmaceutical Industry Report, 2013-2016

Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than tha...

China Pharmaceutical Distribution Industry Report, 2013

Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of rou...

China Pharmaceutical Glass Packaging Industry Report, 2013-2016

Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceuti...

China Chinese Patent Medicine Industry Report, 2013-2016

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance...

Global and China Insulin Industry Report, 2013-2017

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 3...

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese prepar...

China Vitamin Industry Report, 2012-2015

As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of ...

China Pharmaceutical Equipment Industry Report, 2012-2015

Driven by the new GMP certification as well as the brisk downstream demand, China pharmaceutical equipment industry has seen steady progress in sales volume and technological content of products over ...

China Genetic Engineering Drug Industry Report, 2011-2012

China gets a late start in developing genetic engineering drug industry, but has achieved leapfrog advance. At present, China has at least one hundred enterprises involved in genetic engineering drugs...

China Animal Vaccine Industry Report, 2011-2012

Along with the frequent outbreaks of animal epidemics, the government’s increasing investment in epidemic prevention and the implementation of compulsory immunization system, Chinese animal vaccine ma...

2005- All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号